Induced Pluripotent Stem Cells Production Market (By Process; By Workflow: Cell Culture; By Product; By Application: Regenerative Medicine; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Induced Pluripotent Stem Cells Production Market 

5.1. COVID-19 Landscape: Induced Pluripotent Stem Cells Production Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Induced Pluripotent Stem Cells Production Market, By Process

8.1. Induced Pluripotent Stem Cells Production Market, by Process, 2023-2032

8.1.1. Manual iPSC Production Process

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Automated iPSC Production Process

8.1.2.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global Induced Pluripotent Stem Cells Production Market, By Workflow

9.1. Induced Pluripotent Stem Cells Production Market, by Workflow, 2023-2032

9.1.1. Reprogramming

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Cell Culture

9.1.2.1. Market Revenue and Forecast (2019-2032)

9.1.3. Cell Characterization / Analysis

9.1.3.1. Market Revenue and Forecast (2019-2032)

9.1.4. Engineering

9.1.4.1. Market Revenue and Forecast (2019-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global Induced Pluripotent Stem Cells Production Market, By Product 

10.1. Induced Pluripotent Stem Cells Production Market, by Product, 2023-2032

10.1.1. Instruments/ Devices

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. Automated Platforms

10.1.2.1. Market Revenue and Forecast (2019-2032)

10.1.3. Consumables & Kits

10.1.3.1. Market Revenue and Forecast (2019-2032)

10.1.4. Services

10.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global Induced Pluripotent Stem Cells Production Market, By Application

11.1. Induced Pluripotent Stem Cells Production Market, by Application, 2023-2032

11.1.1. Drug Development & Discovery

11.1.1.1. Market Revenue and Forecast (2019-2032)

11.1.2. Regenerative Medicine

11.1.2.1. Market Revenue and Forecast (2019-2032)

11.1.3. Toxicology Studies

11.1.3.1. Market Revenue and Forecast (2019-2032)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 12. Global Induced Pluripotent Stem Cells Production Market, By End-user

12.1. Induced Pluripotent Stem Cells Production Market, by End-user, 2023-2032

12.1.1. Research & Academic Institutes

12.1.1.1. Market Revenue and Forecast (2019-2032)

12.1.2. Biotechnology & Pharmaceutical Companies

12.1.2.1. Market Revenue and Forecast (2019-2032)

12.1.3. Hospitals & Clinics

12.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 13. Global Induced Pluripotent Stem Cells Production Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Process (2019-2032)

13.1.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.1.3. Market Revenue and Forecast, by Product (2019-2032)

13.1.4. Market Revenue and Forecast, by Application (2019-2032)

13.1.5. Market Revenue and Forecast, by End-user (2019-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Process (2019-2032)

13.1.6.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.1.6.3. Market Revenue and Forecast, by Product (2019-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2019-2032)

13.1.7. Market Revenue and Forecast, by End-user (2019-2032) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Process (2019-2032)

13.1.8.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.1.8.3. Market Revenue and Forecast, by Product (2019-2032)

13.1.8.4. Market Revenue and Forecast, by Application (2019-2032)

13.1.8.5. Market Revenue and Forecast, by End-user (2019-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Process (2019-2032)

13.2.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.2.3. Market Revenue and Forecast, by Product (2019-2032)

13.2.4. Market Revenue and Forecast, by Application (2019-2032) 

13.2.5. Market Revenue and Forecast, by End-user (2019-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Process (2019-2032)

13.2.6.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.2.6.3. Market Revenue and Forecast, by Product (2019-2032)

13.2.7. Market Revenue and Forecast, by Application (2019-2032) 

13.2.8. Market Revenue and Forecast, by End-user (2019-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Process (2019-2032)

13.2.9.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.2.9.3. Market Revenue and Forecast, by Product (2019-2032)

13.2.10. Market Revenue and Forecast, by Application (2019-2032)

13.2.11. Market Revenue and Forecast, by End-user (2019-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Process (2019-2032)

13.2.12.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.2.12.3. Market Revenue and Forecast, by Product (2019-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2019-2032)

13.2.13. Market Revenue and Forecast, by End-user (2019-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Process (2019-2032)

13.2.14.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.2.14.3. Market Revenue and Forecast, by Product (2019-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2019-2032)

13.2.15. Market Revenue and Forecast, by End-user (2019-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Process (2019-2032)

13.3.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.3.3. Market Revenue and Forecast, by Product (2019-2032)

13.3.4. Market Revenue and Forecast, by Application (2019-2032)

13.3.5. Market Revenue and Forecast, by End-user (2019-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Process (2019-2032)

13.3.6.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.3.6.3. Market Revenue and Forecast, by Product (2019-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2019-2032)

13.3.7. Market Revenue and Forecast, by End-user (2019-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Process (2019-2032)

13.3.8.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.3.8.3. Market Revenue and Forecast, by Product (2019-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2019-2032)

13.3.9. Market Revenue and Forecast, by End-user (2019-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Process (2019-2032)

13.3.10.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.3.10.3. Market Revenue and Forecast, by Product (2019-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2019-2032)

13.3.10.5. Market Revenue and Forecast, by End-user (2019-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Process (2019-2032)

13.3.11.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.3.11.3. Market Revenue and Forecast, by Product (2019-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2019-2032)

13.3.11.5. Market Revenue and Forecast, by End-user (2019-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Process (2019-2032)

13.4.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.4.3. Market Revenue and Forecast, by Product (2019-2032)

13.4.4. Market Revenue and Forecast, by Application (2019-2032)

13.4.5. Market Revenue and Forecast, by End-user (2019-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Process (2019-2032)

13.4.6.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.4.6.3. Market Revenue and Forecast, by Product (2019-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2019-2032)

13.4.7. Market Revenue and Forecast, by End-user (2019-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Process (2019-2032)

13.4.8.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.4.8.3. Market Revenue and Forecast, by Product (2019-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2019-2032)

13.4.9. Market Revenue and Forecast, by End-user (2019-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Process (2019-2032)

13.4.10.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.4.10.3. Market Revenue and Forecast, by Product (2019-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2019-2032)

13.4.10.5. Market Revenue and Forecast, by End-user (2019-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Process (2019-2032)

13.4.11.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.4.11.3. Market Revenue and Forecast, by Product (2019-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2019-2032)

13.4.11.5. Market Revenue and Forecast, by End-user (2019-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Process (2019-2032)

13.5.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.5.3. Market Revenue and Forecast, by Product (2019-2032)

13.5.4. Market Revenue and Forecast, by Application (2019-2032)

13.5.5. Market Revenue and Forecast, by End-user (2019-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Process (2019-2032)

13.5.6.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.5.6.3. Market Revenue and Forecast, by Product (2019-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2019-2032)

13.5.7. Market Revenue and Forecast, by End-user (2019-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Process (2019-2032)

13.5.8.2. Market Revenue and Forecast, by Workflow (2019-2032)

13.5.8.3. Market Revenue and Forecast, by Product (2019-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2019-2032)

13.5.8.5. Market Revenue and Forecast, by End-user (2019-2032)

Chapter 14. Company Profiles

14.1. Lonza

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Axol Biosciences Ltd.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Evotec SE

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Hitachi Ltd.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Merck KGaA

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. REPROCELLS, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Fate Therapeutics

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Thermo Fisher Scientific, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. StemCellsFactory III

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Applied StemCells, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms